CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
3.910
0.00 (0.00%)
Sep 18, 2024, 4:00 PM EDT - Market closed

CalciMedica Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
8.799.525.845.064.85
Research & Development
12.6612.368.3516.489.65
Operating Expenses
21.4521.8814.1921.5414.5
Operating Income
-21.45-21.88-14.19-21.54-14.5
Interest Expense
--0.11-0.13--0.04
Interest & Investment Income
10.7---
Other Non Operating Income (Expenses)
5.841.113.76-1.960.32
EBT Excluding Unusual Items
-14.61-20.18-10.57-23.5-14.22
Merger & Restructuring Charges
--16.2---
Other Unusual Items
2.022.022.75--0.96
Pretax Income
-12.59-34.36-7.82-23.5-15.18
Net Income
-12.59-34.36-7.82-23.5-15.18
Preferred Dividends & Other Adjustments
--1.32--
Net Income to Common
-12.59-34.36-9.14-23.5-15.18
Shares Outstanding (Basic)
84033
Shares Outstanding (Diluted)
84033
Shares Change (YoY)
383.85%5354.75%-96.97%3.08%-
EPS (Basic)
-1.56-7.66-111.16-8.65-5.76
EPS (Diluted)
-1.56-7.66-111.16-8.65-5.76
Free Cash Flow
-19.69-25.81-11.76-20.72-9.85
Free Cash Flow Per Share
-2.44-5.75-143.00-7.63-3.74
EBITDA
-21.39-21.82-14.14-21.5-14.5
D&A For EBITDA
0.060.060.050.040.01
EBIT
-21.45-21.88-14.19-21.54-14.5
Source: S&P Capital IQ. Standard template. Financial Sources.